Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Section: Veterinary Medicine

Early Stages Of Mange In Dogs: Comprehensive Veterinary Reference Guide

Introduction

Mange is a common yet often distressing parasitic skin disease affecting dogs worldwide. Caused by microscopic mites, mange can lead to significant discomfort, secondary infections, and, if left untreated, severe systemic illness. For pet owners and veterinary professionals alike, recognizing the early stages of mange in dogs is critical for prompt intervention, improved outcomes, and reduced suffering. This comprehensive veterinary reference guide provides an exhaustive, publication-grade overview of the early clinical presentation, diagnostic approaches, treatment protocols, and preventive strategies for canine mange. Drawing on authoritative guidelines from organizations such as the American Veterinary Medical Association (AVMA), the American Animal Hospital Association (AAHA), the Canadian Veterinary Medical Association (CVMA), the Australian Veterinary Association (AVA), and the Federation of Veterinarians of Europe (FVE), this article serves as a definitive resource for understanding and managing this condition from its earliest manifestations.

Mange is primarily categorized into two forms: sarcoptic mange (also known as scabies), caused by Sarcoptes scabiei var. canis, and demodectic mange (also called demodicosis or red mange), caused by Demodex canis mites. While both conditions involve mite infestation of the skin, their pathophysiology, clinical signs, and management differ substantially. The early stages of mange in dogs can be subtle, often mimicking other dermatological conditions such as allergies, bacterial pyoderma, or fungal infections. Therefore, a thorough understanding of the initial signs, diagnostic techniques, and differential diagnoses is essential.

This guide is structured to address the needs of both pet owners seeking to understand what to look for and veterinary staff requiring a detailed clinical reference. We will cover the biology of mange mites, the earliest observable symptoms, diagnostic methods including skin scrapings and trichography, treatment options ranging from topical therapies to systemic medications, and preventive measures. Additionally, we will incorporate regional considerations for North America, Europe, Australia, and Canada, including variations in mite prevalence, treatment availability, and regulatory guidelines.

By the end of this article, readers will have a comprehensive understanding of how to identify and manage the early stages of mange in dogs, empowering them to take swift, informed action. This guide is intended to complement, not replace, professional veterinary consultation. Always consult a licensed veterinarian for diagnosis and treatment recommendations.

Quick Q&A

Question: What are the first signs of mange in dogs that I should look for at home? Answer: The earliest signs of mange in dogs often include intense itching (pruritus), redness (erythema), and small bumps or papules, particularly on the ears, elbows, hocks, and belly. You may also notice hair loss (alopecia) in patches and the formation of crusts or scales. If you observe these symptoms, especially if they worsen rapidly, consult your veterinarian for a proper diagnosis.

Understanding Mange: The Mites Behind the Disease

Mange is not a single disease but a term encompassing several parasitic skin conditions caused by different species of mites. The two primary forms affecting dogs are sarcoptic mange and demodectic mange. Understanding the biology and life cycle of these mites is foundational to recognizing the early stages of mange in dogs.

Sarcoptic Mange (Scabies)

Causative Agent: Sarcoptes scabiei var. canis. This mite is highly contagious and can be transmitted between dogs and, occasionally, to humans (causing a self-limiting condition known as pseudoscabies).

Life Cycle: The entire life cycle of the sarcoptic mite occurs on the host, typically lasting 17 to 21 days. Adult female mites burrow into the stratum corneum of the skin, creating tunnels where they lay eggs. Larvae hatch within 3 to 10 days, molt into nymphs, and then into adults. The mites feed on skin cells and tissue fluids, triggering an intense allergic reaction in the host.

Early Stage Pathophysiology: In the early stages, the allergic response to mite saliva, feces, and eggs is the primary driver of clinical signs. This hypersensitivity reaction leads to intense pruritus (itching), which is often out of proportion to the visible skin lesions. The early stages of mange in dogs with sarcoptic mange are characterized by erythema (redness) and papules (small, raised bumps) on areas with thin hair, such as the pinnae (ear flaps), elbows, hocks, and ventral abdomen. The "ear-pedal reflex" (scratching the ear when the ear margin is rubbed) is a classic early sign.

Demodectic Mange (Demodicosis)

Causative Agent: Demodex canis is a normal inhabitant of the canine skin, residing in hair follicles and sebaceous glands. In healthy dogs, the immune system keeps the mite population in check. Demodicosis occurs when there is an overpopulation of mites, often due to immunosuppression or genetic predisposition.

Life Cycle: The entire life cycle of Demodex canis (approximately 20 to 35 days) occurs within the hair follicle. Female mites lay eggs, which hatch into larvae, then nymphs, and finally adults. Transmission occurs from dam to puppy during nursing, typically within the first few days of life. The mites are not considered contagious to other dogs or humans.

Early Stage Pathophysiology: In the early stages of demodectic mange, the overpopulation of mites within hair follicles leads to folliculitis (inflammation of the hair follicle). This results in localized hair loss (alopecia), often around the eyes, lips, and forelimbs. The skin may appear red, scaly, or have a "moth-eaten" appearance. Pruritus is variable and may be mild or absent initially, distinguishing it from sarcoptic mange. Secondary bacterial infections are common and can exacerbate the condition.

Recognizing the Early Stages of Mange in Dogs

Early detection is paramount for effective treatment and prevention of complications. The clinical signs of mange can be subtle and easily mistaken for other conditions. This section provides a detailed breakdown of the early stages of mange in dogs, organized by type.

Early Signs of Sarcoptic Mange

The hallmark of early sarcoptic mange is intense, relentless pruritus. Dogs will scratch, bite, lick, and rub affected areas incessantly. This itching often worsens at night or in warm environments.

Primary Lesions (Early Stage):

  • Erythema: Redness, particularly on the pinnae (ear flaps), elbows, hocks, and ventral abdomen.
  • Papules: Small (1-3 mm), raised, red bumps. These may be difficult to see in dogs with thick coats.
  • Crusts and Scales: As the condition progresses, small, yellowish crusts (scabs) may form, especially on the ear margins.
  • Alopecia: Hair loss is initially patchy and may be subtle. It often begins on the ears, elbows, and hocks.

Commonly Affected Areas (Early Stage):

  • Ear Pinnae: The ear margins are a classic early site. The "ear-pedal reflex" is often positive.
  • Elbows and Hocks: These bony prominences are frequently affected.
  • Ventral Abdomen and Chest: The thin skin in these areas is susceptible.
  • Face and Periocular Area: Less common in early sarcoptic mange but can occur.

Behavioral Changes:

  • Restlessness
  • Frequent scratching or rubbing against furniture
  • Self-trauma (excoriations, broken hair shafts)

Early Signs of Demodectic Mange

Demodectic mange often presents more insidiously. The early stages of mange in dogs with demodicosis are characterized by localized alopecia without significant pruritus in many cases.

Primary Lesions (Early Stage):

  • Localized Alopecia: Small, well-defined patches of hair loss, often around the eyes (periocular), lips (perioral), and on the forelimbs. The hair loss may have a "moth-eaten" appearance.
  • Erythema: The skin in the alopecic areas may be mildly red or pink.
  • Scaling and Comedones: Fine scales (dandruff) and blackheads (comedones) may be present.
  • Papules and Pustules: In some cases, secondary bacterial infection (pyoderma) can occur early, leading to papules and pustules.

Commonly Affected Areas (Early Stage):

  • Face: Especially around the eyes and mouth.
  • Forelimbs: The front legs are a common site.
  • Trunk: Less common in the localized form.

Behavioral Changes:

  • Pruritus is often absent or mild in the early stages. If present, it is usually due to secondary bacterial infection.
  • Dogs may appear otherwise healthy.

Differentiating Early Sarcoptic vs. Demodectic Mange

| Feature | Early Sarcoptic Mange | Early Demodectic Mange | | :-, | :-, | :-, | | Pruritus | Intense, relentless, often worse at night | Mild or absent initially | | Primary Lesion | Papules, erythema, crusts | Localized alopecia, scaling | | Distribution | Ears, elbows, hocks, ventral abdomen | Face (eyes, mouth), forelimbs | | Contagious | Highly contagious to dogs and humans | Not contagious (except from dam to pup) | | Ear-Pedal Reflex | Often positive | Usually negative |

Diagnostic Approaches for Early Mange

Accurate diagnosis in the early stages of mange in dogs is essential to avoid misdiagnosis and inappropriate treatment. A combination of history, physical examination, and specific diagnostic tests is used.

History and Signalment

  • Signalment: Age, breed, and lifestyle are important. Young dogs (under 2 years) are more prone to demodicosis, while sarcoptic mange can affect any age. Breeds predisposed to demodicosis include Bulldogs, Shar-Peis, and West Highland White Terriers.
  • History: Onset of pruritus, progression, contact with other animals, recent boarding or grooming, and response to previous treatments (e.g., steroids may worsen demodicosis).

Physical Examination

A thorough dermatological examination is performed, noting the distribution and morphology of lesions. The "ear-pedal reflex" is a useful clinical test for sarcoptic mange. To perform this, the examiner rubs the ear margin of the affected dog. A positive reflex is indicated by the dog scratching its ear with its hind limb.

Diagnostic Tests

  1. Skin Scraping: This is the gold standard for diagnosing mange. A scalpel blade is used to scrape the skin in affected areas, collecting superficial and deep skin debris. The material is placed in mineral oil and examined under a microscope.

    • Sarcoptic Mange: Mites are often difficult to find due to their low numbers and burrowing behavior. Multiple scrapings from different sites (especially ear margins and elbows) may be needed. Finding eggs, larvae, or fecal pellets can also confirm the diagnosis.
    • Demodectic Mange: Deep skin scrapings are more effective. Demodex mites are easily identified as cigar-shaped organisms with eight legs. Finding more than one mite per low-power field or any mites in a healthy dog is considered abnormal.
  2. Trichography (Hair Pluck): Plucking hair from affected areas and examining the hair shafts under the microscope can reveal Demodex mites attached to the hair follicle. This is particularly useful for demodicosis.

  3. Acetate Tape Preparation: Pressing a piece of clear tape against the skin and then examining it under the microscope can sometimes capture mites, eggs, or secondary bacteria.

  4. Fecal Flotation: Occasionally, mites may be ingested during grooming and can be found in fecal samples, though this is not a primary diagnostic method.

  5. Response to Treatment: In cases where skin scrapings are negative but clinical suspicion for sarcoptic mange is high, a therapeutic trial with an acaricidal medication (e.g., selamectin, ivermectin) can be diagnostic. Improvement within 2-4 weeks supports the diagnosis.

  6. Biopsy: In rare, atypical cases, a skin biopsy may be necessary to differentiate mange from other conditions like dermatophytosis or autoimmune disease.

Differential Diagnoses

The early stages of mange in dogs can mimic several other conditions. A thorough diagnostic workup is essential to rule out:

  • Allergic Dermatitis (Atopy, Food Allergy): Pruritus is common, but distribution is often different (face, paws, axillae). Skin scrapings are negative.
  • Bacterial Pyoderma: Pustules and crusts are present, but pruritus is variable. Cytology and culture can differentiate.
  • Dermatophytosis (Ringworm): Circular areas of alopecia with scaling. Fungal culture or PCR is diagnostic.
  • Seborrhea: Primary or secondary scaling disorders. Skin scrapings are negative.
  • Autoimmune Diseases (e.g., Pemphigus Foliaceus): Crusting, pustules, and erosions. Biopsy is needed.

Treatment Protocols for Early Mange

Treatment depends on the type of mange, severity, and the dog's overall health. Early intervention in the early stages of mange in dogs is associated with better outcomes and fewer complications.

Treatment for Early Sarcoptic Mange

The goal is to eliminate the mites and control the intense pruritus.

Topical Therapies:

  • Lime Sulfur Dips: Safe for puppies and pregnant dogs. Applied weekly for 4-6 weeks. Can be messy and have a strong odor.
  • Amitraz Dips: Effective but not approved for use in all countries (e.g., restricted in some European nations). Contraindicated in small breed dogs, diabetic dogs, and pregnant/nursing dogs.
  • Selamectin (Revolution/Stronghold): A topical spot-on that is effective against sarcoptic mites. Applied monthly. Safe for puppies as young as 6 weeks.
  • Moxidectin/Imidacloprid (Advantage Multi/Advocate): Another topical spot-on with efficacy against sarcoptic mange.

Systemic Therapies:

  • Ivermectin: Oral or injectable. Effective but must be used with caution in breeds with MDR1 gene mutation (e.g., Collies, Shelties, Australian Shepherds). A genetic test is recommended before use.
  • Milbemycin Oxime (Interceptor): Oral. Safe for MDR1-sensitive breeds. Given daily for 30-60 days.
  • Afoxolaner (NexGard), Fluralaner (Bravecto), Sarolaner (Simparica), Lotilaner (Credelio): These isoxazoline class drugs are highly effective against sarcoptic mites. They are administered orally and provide rapid relief. Fluralaner provides up to 12 weeks of efficacy.

Supportive Care:

  • Antipruritics: In severe cases, corticosteroids (e.g., prednisone) may be used short-term to control itching, but they should be used cautiously as they can be immunosuppressive.
  • Antibiotics: Secondary bacterial infections are common. A course of appropriate antibiotics (e.g., cephalexin, amoxicillin-clavulanate) may be necessary.
  • Medicated Shampoos: Chlorhexidine or benzoyl peroxide shampoos can help manage secondary infections and remove crusts.

Environmental Control:

  • Sarcoptic mites can survive off the host for a few days. Wash bedding, collars, and grooming tools in hot water. Vacuum thoroughly. Treat the environment with an acaricidal spray if recommended by your veterinarian.

Treatment for Early Demodectic Mange

The approach depends on whether the demodicosis is localized or generalized.

Localized Demodicosis (Early Stage):

  • Often self-limiting, especially in young dogs. The immune system may resolve the infestation without treatment.
  • Topical Therapy: Daily application of a 1% rotenone ointment or benzoyl peroxide gel to affected areas can help.
  • Monitoring: Recheck in 4-8 weeks. If lesions worsen or spread, systemic therapy may be indicated.

Generalized Demodicosis (If Early Stage Progresses):

  • Requires aggressive systemic therapy.
  • Amitraz Dips: Weekly dips for 4-6 weeks. Not approved in all regions.
  • Ivermectin: Oral, daily. Requires careful dosing and monitoring. Contraindicated in MDR1-sensitive breeds.
  • Milbemycin Oxime: Oral, daily. Safe for MDR1-sensitive breeds.
  • Isoxazolines: Fluralaner (Bravecto) and afoxolaner (NexGard) have shown excellent efficacy against Demodex mites. They are often preferred due to ease of administration and safety profile. Treatment may need to be repeated monthly or every 3 months until negative skin scrapings are achieved.

Supportive Care:

  • Antibiotics: For secondary pyoderma, which is common.
  • Medicated Shampoos: Benzoyl peroxide shampoos help flush hair follicles and reduce mite burden.
  • Immunomodulation: In cases of underlying immunosuppression, addressing the primary cause (e.g., hypothyroidism, Cushing's disease) is critical.

Monitoring:

  • Monthly skin scrapings are performed to assess treatment response. Treatment is continued until two consecutive negative scrapings are obtained, typically 1-2 months after clinical resolution.

Regional Considerations in Mange Management

Veterinary practice varies by region due to differences in mite prevalence, regulatory approvals, and common treatment protocols.

North America (USA and Canada)

  • Prevalence: Sarcoptic mange is common in shelters and areas with high dog populations. Demodicosis is more common in purebred dogs.
  • Regulatory: Amitraz dips are approved for use in the USA but are less commonly used now due to the availability of safer systemic options. Isoxazolines (NexGard, Bravecto, Simparica) are widely used and approved for both sarcoptic and demodectic mange.
  • Guidelines: The AVMA and AAHA provide guidelines for parasite control, including mange. The Companion Animal Parasite Council (CAPC) publishes annual recommendations.
  • Canadian Specifics: The CVMA supports similar guidelines. In Canada, selamectin (Revolution) and moxidectin/imidacloprid (Advantage Multi) are commonly used for sarcoptic mange.

Europe

  • Prevalence: Sarcoptic mange is a significant concern, especially in stray and shelter dogs. Demodicosis is also seen.
  • Regulatory: The European Medicines Agency (EMA) and national authorities regulate veterinary medicines. Isoxazolines are approved and widely used. Amitraz dips are available but restricted in some countries.
  • Guidelines: The Federation of Veterinarians of Europe (FVE) and the European Scientific Counsel for Companion Animal Parasites (ESCCAP) provide guidelines. ESCCAP recommends isoxazolines as first-line treatment for sarcoptic mange.

Australia

  • Prevalence: Sarcoptic mange is common in rural and remote areas, particularly in dingoes and free-roaming dogs. Demodicosis is also prevalent.
  • Regulatory: The Australian Pesticides and Veterinary Medicines Authority (APVMA) regulates treatments. Isoxazolines are available. Fluralaner (Bravecto) is widely used.
  • Guidelines: The Australian Veterinary Association (AVA) and the Department of Agriculture, Fisheries and Forestry (DAFF) provide guidance. There is a focus on preventing resistance and managing zoonotic risk (sarcoptic mange can be transmitted to humans).

Prevention and Long-Term Management

Preventing the early stages of mange in dogs involves a combination of good husbandry, parasite control, and immune support.

General Preventive Measures

  • Regular Parasite Control: Use a broad-spectrum antiparasitic that covers mites. Monthly topical or oral products (e.g., selamectin, isoxazolines) can prevent sarcoptic mange.
  • Avoid Contact with Infected Animals: Keep dogs away from stray or unknown animals, especially in high-risk areas.
  • Quarantine New Dogs: New additions to the household should be isolated for 2-4 weeks and screened for skin disease.
  • Good Nutrition and Stress Reduction: A balanced diet and low-stress environment support a healthy immune system, which is crucial for preventing demodicosis.
  • Regular Veterinary Check-ups: Annual or bi-annual exams allow for early detection of skin issues.

Specific Prevention for Demodicosis

  • Breeding Considerations: Do not breed dogs with a history of generalized demodicosis, as it may be hereditary.
  • Neutering: Some studies suggest that neutering may reduce the risk of demodicosis in predisposed breeds, but this is not definitive.

Long-Term Management

  • For Sarcoptic Mange: Once treated, dogs are immune to reinfestation for several months. However, they can be reinfected if exposed. Year-round parasite control is recommended.
  • For Demodicosis: Dogs that have had generalized demodicosis may have a lifelong predisposition. They should be monitored for recurrence, especially during periods of stress or illness. Routine skin scrapings may be recommended every 6-12 months.

When to Seek Veterinary Care

Pet owners should seek veterinary care immediately if they observe any of the following signs, which may indicate the early stages of mange in dogs:

  • Intense, unexplained itching that is not relieved by over-the-counter remedies.
  • Sudden hair loss in patches, especially on the face, ears, or legs.
  • Red, scaly, or crusty skin that is not healing.
  • Any skin lesion that is spreading or worsening.
  • Lethargy, fever, or loss of appetite (may indicate secondary infection or severe infestation).
  • If you suspect your dog has been exposed to a known mangy animal.

Prognosis

The prognosis for the early stages of mange in dogs is generally excellent with appropriate treatment.

  • Sarcoptic Mange: With prompt diagnosis and treatment, most dogs recover completely within 4-6 weeks. Secondary infections are common but manageable.
  • Demodectic Mange: Localized demodicosis in young dogs often resolves spontaneously. Generalized demodicosis requires aggressive treatment but has a good prognosis if the underlying cause is addressed and the dog is otherwise healthy. Chronic, recurrent cases may be more challenging.

Frequently Asked Questions (FAQs)

Q: Can I get mange from my dog? A: Yes, sarcoptic mange is zoonotic. The mites can burrow into human skin, causing a red, itchy rash (pseudoscabies). However, the mites cannot complete their life cycle on humans, and the condition is self-limiting once the dog is treated. Demodectic mange is not contagious to humans.

Q: How long does it take to see results from treatment? A: For sarcoptic mange, itching often improves within 1-2 weeks of starting treatment. Complete resolution of skin lesions may take 4-6 weeks. For demodectic mange, hair regrowth may be seen within 4-8 weeks, but treatment is continued until skin scrapings are negative.

Q: Are there any home remedies for early mange? A: While some home remedies (e.g., apple cider vinegar, coconut oil) are promoted online, they are not effective for treating mange and may delay proper veterinary care. Some can even irritate the skin. Always consult a veterinarian for safe and effective treatment.

Q: Can mange be cured without medication? A: In some cases of localized demodicosis in young dogs, the immune system can resolve the condition without treatment. However, sarcoptic mange requires acaricidal medication. Relying on natural resolution can lead to severe disease and spread to other animals and humans.

Q: Is mange more common in certain dog breeds? A: Yes. Demodicosis is more common in breeds such as Bulldogs, Shar-Peis, West Highland White Terriers, and Great Danes. Sarcoptic mange can affect any breed but is more common in dogs with high exposure to other dogs (e.g., shelter dogs, hunting dogs).

Conclusion

The early stages of mange in dogs present a critical window for intervention. Recognizing the subtle signs of intense pruritus, localized alopecia, and erythema can lead to prompt diagnosis and effective treatment, preventing progression to severe, debilitating disease. This comprehensive veterinary reference guide has provided an in-depth look at the pathophysiology, clinical presentation, diagnostic methods, and treatment options for both sarcoptic and demodectic mange. By adhering to evidence-based guidelines from authoritative bodies such as the AVMA, AAHA, CVMA, AVA, and FVE, veterinary professionals and pet owners can work together to ensure the best possible outcomes.

Early diagnosis is key. A thorough history, physical examination, and appropriate diagnostic tests (especially skin scrapings) are essential to differentiate mange from other pruritic skin conditions. Treatment should be tailored to the specific type of mange, the severity of the disease, and the individual dog's health status. With the advent of safe and highly effective systemic therapies like isoxazolines, managing mange has become more straightforward than ever.

Prevention remains the best strategy. Regular use of broad-spectrum antiparasiticides, avoiding contact with infected animals, and maintaining a healthy immune system through good nutrition and stress reduction are fundamental. For dogs with a history of demodicosis, lifelong monitoring may be necessary.

In summary, the early stages of mange in dogs are highly treatable, and with vigilant observation and timely veterinary care, affected dogs can return to full health and comfort. This guide serves as a definitive resource for navigating this common yet manageable condition.

References

  1. Miller, W. H., Griffin, C. E., & Campbell, K. L. (2013). Muller and Kirk's Small Animal Dermatology (7th ed.). St. Louis, MO: Elsevier.
  2. Scott, D. W., Miller, W. H., & Griffin, C. E. (2001). Muller and Kirk's Small Animal Dermatology (6th ed.). Philadelphia, PA: W.B. Saunders.
  3. Medleau, L., & Hnilica, K. A. (2006). Small Animal Dermatology: A Color Atlas and Therapeutic Guide (2nd ed.). St. Louis, MO: Saunders Elsevier.
  4. American Veterinary Medical Association (AVMA). (2023). Canine Mange. Retrieved from avma.org.
  5. American Animal Hospital Association (AAHA). (2022). AAHA Canine Vaccination Guidelines. Retrieved from aaha.org.
  6. Canadian Veterinary Medical Association (CVMA). (2021). Parasite Control in Dogs. Retrieved from canadianveterinarians.net.
  7. Australian Veterinary Association (AVA). (2023). Mange in Dogs. Retrieved from ava.com.au.
  8. Federation of Veterinarians of Europe (FVE). (2022). Position on Parasite Control. Retrieved from fve.org.
  9. European Scientific Counsel for Companion Animal Parasites (ESCCAP). (2021). ESCCAP Guideline 3: Control of Ectoparasites in Dogs and Cats (7th ed.). Retrieved from esccap.org.
  10. Companion Animal Parasite Council (CAPC). (2023). Canine Mange. Retrieved from capcvet.org.
  11. Merck Veterinary Manual. (2023). Mange in Dogs. Retrieved from merckvetmanual.com.
  12. VCA Animal Hospitals. (2023). Mange in Dogs. Retrieved from vcahospitals.com.
  13. DVM360. (2022). Advances in Mange Treatment. Retrieved from dvm360.com.
  14. Department of Agriculture, Fisheries and Forestry (DAFF), Australia. (2023). Animal Health: Mange. Retrieved from agriculture.gov.au.
  15. European Medicines Agency (EMA). (2022). Veterinary Medicines: Isoxazolines. Retrieved from ema.europa.eu.